News

Pharmaceutical Technology32m
France halts Valneva’s chikungunya vaccine use in seniors
French health authorities have suspended the use of Valneva’s chikungunya vaccine Ixchiq in adults aged 65 and older after ...
Pharmaceutical Technology5h
J&J’s Tremfya gains EC marketing authorisation for ulcerative colitis
The EC has granted marketing authorisation for Johnson & Johnson's (J&J) Tremfya to treat adults with ulcerative colitis (UC) ...
Pharmaceutical Technology7h
Innorna secures dual FDA designations for Wilson’s disease mRNA therapy
The FDA has granted rare paediatric disease and orphan drug designations for IN013, Innorna's mRNA therapeutic for Wilson's ...
Pharmaceutical Technology9h
Amgen to invest $900m in Ohio manufacturing facility
Amgen has announced a significant expansion of the Ohio manufacturing facility in the US, with an investment of $900m.
Pharmaceutical Technology8h
Merck KGaA strikes $3.9bn deal for SpringWorks
Merck has moved to strengthen its position in oncology and rare diseases with a $3.9bn agreement to acquire SpringWorks ...
Pharmaceutical Technology11h
China approves InnoCare Pharma’s BTK inhibitor for lymphoma
China’s NMPA has approved InnoCare Pharma’s orelabrutinib for use as a first-line treatment for CLL and small lymphocytic ...